Nyt fra tidsskrifterne
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Klik på linket nedenfor, tryk derefter Ctrl + C eller højreklik for at kopiere det.
Ingen søgeord valgt. Opdateret for 3 timer siden.
17 emner vises.
Julia Alcoba-Florez, Helena Gil-Campesino, Diego García-Martínez de Artola, Oscar Díez-Gil, Agustín Valenzuela-Fernández, Rafaela González-Montelongo, Laura Ciuffreda, Carlos Flores
International Journal of Infectious Diseases, 18.11.2020 Tilføjet 19.11.2020 03:26The SARS-CoV-2 pandemic causing COVID-19 continue imposing a heavy burden on healthcare systems worldwide because of a shortage of consumables and the demand for scaling up efficient screening approaches. To limit the escalation of cases and amplification of infections, increasing the capacities and developing alternatives to the one-step reverse transcription and real-time quantitative PCR (RT-qPCR) for regular testing of SARS-CoV-2 is key (Mina et al. 2020). We have assessed a direct heating method of nasopharyngeal (swab) samples to bypass the RNA extraction step for increasing the testing capacity (Alcoba-Florez et al.
Læs mere Tjek på PubMedJinghao Nicholas Ngiam, Nicholas Chew, Sai Meng Tham, Darius Lian-Lian Beh, Zhen Yu Lim, Tony Y.W. Li, Shuyun Cen, Paul Anantharajah Tambyah, Amelia Santosa, Ching-Hui Sia, Gail Brenda Cross
International Journal of Infectious Diseases, 18.11.2020 Tilføjet 19.11.2020 03:26Singapore was uniquely susceptible to the global Coronavirus Disease 2019 (COVID-19) pandemic as one of the most densely populated countries in the world (8358 per km2). It sees a high volume of travellers for both business and tourism particularly from China (Lim et al. 2012). The public health system in Singapore was put to the test by the severe acute respiratory syndrome (SARS) outbreak in 2003, and the lessons learned prepared it well for the challenges faced by COVID-19 in 2020. Whilst Singapore acted quickly, it focused on transmission amongst those with symptomatic diseases in the community, with delayed recognition of the importance of pre-symptomatic/asymptomatic transmission, particularly in vulnerable settings like migrant worker dormitories.
Læs mere Tjek på PubMedQuang Van Nguyen, Dung Anh Cao, Son Hong Nghiem
International Journal of Infectious Diseases, 18.11.2020 Tilføjet 19.11.2020 03:26The emergence of the coronavirus disease 2019 (COVID-19) pandemic has spread rapidly across the globe since December 2019. As of 26 October 2020, more than 43.5 million of COVID-19 confirmed cases had been reported with almost 1.2 million associated deaths (Johns Hopkins University, 2020). Furthermore, the number of confirmed cases still increases rapidly in many countries (World Health Organisation, 2020).
Læs mere Tjek på PubMedIvan Ilic, Marina Zdravkovic, Stefan Timcic, Dragana Unic Stojanovic, Milovan Bojic, Goran Loncar
International Journal of Infectious Diseases, 18.11.2020 Tilføjet 19.11.2020 03:26Coronavirus disease (COVID-19) caused by RNA virus has caused a worldwide pandemic. The infection can present with various clinical scenarios, ranging from completely asymptomatic course to life-threatening forms of acute respiratory distress syndrome and multi-organ failure (Guan et al., 2020). The disease was first reported as an unusual form of pneumonia in Wuhan, Hubei province, China in December 2019 (Huang et al., 2020). Multi-slice CT has been extensively used for early identification of COVID-19 pneumonia.
Læs mere Tjek på PubMedInfection, 1.12.2020 Tilføjet 19.11.2020 03:06
Toshiro Hirai, Yi Yang, Yukari Zenke, Haiyue Li, Virendra K. Chaudhri, Jacinto S. De La Cruz Diaz, Paul Yifan Zhou, Breanna Anh-Thu Nguyen, Laurent Bartholin, Creg J. Workman, David W. Griggs, Dario A.A. Vignali, Harinder Singh, David Masopust, Daniel H. Kaplan
Immunity, 18.11.2020 Tilføjet 19.11.2020 03:06Epidermal residence of CD8+ memory T cells requires TGFβ, but the source of this cytokine and the relevance of this requirement are unclear. Hirai et al. reveal that interclonal competition for transactivation of autocrine TGFβ preferentially enriches for antigen-specific T cells at the skin barrier.
Læs mere Tjek på PubMedEmerging Infectious Diseases, 16.11.2020 Tilføjet 19.11.2020 03:06
Emerging Infectious Diseases, 16.11.2020 Tilføjet 19.11.2020 03:06
Emerging Infectious Diseases, 30.09.2020 Tilføjet 19.11.2020 03:06
Emerging Infectious Diseases, 18.11.2020 Tilføjet 19.11.2020 03:06
Emerging Infectious Diseases, 18.11.2020 Tilføjet 19.11.2020 03:06
Rind, E., Kimpel, K., Preiser, C., Papenfuss, F., Wagner, A., Alsyte, K., Siegel, A., Klink, A., Steinhilber, B., Kauderer, J., Rieger, M. A.
BMJ Open, 18.11.2020 Tilføjet 19.11.2020 03:05Introduction Currently, many countries, affected by the COVID-19 pandemic, discuss how the ‘lockdown-restrictions’ could be lifted to restart the economy and public life after the first wave of the COVID-19 disease has subsided. This study protocol describes an approach designed to provide an in-depth understanding of how companies and their employees in Germany deal with their working conditions during the COVID-19 pandemic. We are also interested in how and why the risk of infection with SARS-CoV-2 could vary across different professional activities, company sites and regions with different epidemiological activity or infection control measures in Germany. We expect the results of this study to contribute to the development of working conditions protecting the health of employees during and beyond the COVID-19 pandemic. Methods and analysis An explorative multimodal mixed methods approach will be applied. Module 1 comprises a document analysis of prevailing federal and regional laws and regulations at the respective location of the participating company. Module 2 includes qualitative interviews with key actors at different companies. Module 3 is a repeated standardised employee survey designed to capture potential changes in the participants’ experiences and attitudes towards working conditions, occupational safety regulations/measures, and infection control measures during the COVID-19 pandemic. Module 4 comprises SARS-CoV-2 seroprevalence testing. This is carried out by the medical service of the participating company sites as a voluntary offer for employees. Qualitative data will be analysed through document and content analysis. The complexity of the quantitative analysis depends on the response rates of modules 3 and 4. Ethics and dissemination The approval of the study design was received in June 2020 from the responsible local ethical committee of the Medical Faculty, University of Tübingen and University Hospital Tübingen (No. 423/2020BO). The results will be presented at national and international conferences and published in peer-reviewed journals.
Læs mere Tjek på PubMedGeorge, C. E., Inbaraj, L. R., Rajukutty, S., de Witte, L. P.
BMJ Open, 18.11.2020 Tilføjet 19.11.2020 03:05Objectives To describe the initial dilemmas, mental stress, adaptive measures implemented and how the healthcare team collectively coped while providing healthcare services in a large slum in India, during the COVID-19 pandemic. Setting Community Health Division, Bangalore Baptist Hospital, Bangalore. Study design We used mixed methods research with a quantitative (QUAN) paradigm nested in the primary qualitative (QUAL) design. QUAL methods included ethnography research methods, in-depth interviews and focus group discussions. Participants A healthcare team of doctors, nurses, paramedical and support staff. Out of 87 staff, 42 participated in the QUAL methods and 64 participated in the QUAN survey. Results Being cognizant of the extreme vulnerability of the slums, the health team struggled with conflicting thoughts of self-preservation and their moral obligation to the marginalised section of society. Majority (75%) of the staff experienced fear at some point in time. Distracting themselves with hobbies (20.3%) and spending more time with family (39.1%) were cited as a means of emotional regulation by the participants in the QUAN survey. In the QUAL interviews, fear of death, the guilt of disease transmission to their loved ones, anxiety about probable violence and stigma in the slums and exhaustion emerged as the major themes causing stress among healthcare professionals. With positive cognitive reappraisal, the health team collectively designed and implemented adaptive interventions to ensure continuity of care. They dealt with the new demands by positive reframing, peer support, distancing, information seeking, response efficacy, self-efficacy, existential goal pursuit, value adherence and religious coping. Conclusion The novel threat of the COVID-19 pandemic threw insurmountable challenges potentiating disastrous consequences; slums becoming a threat to themselves, threat to the health providers and a threat for all. Perhaps, a lesson we could learn from this pandemic is to incorporate ‘slum health’ within universal healthcare.
Læs mere Tjek på PubMedDegeling, C., Chen, G., Gilbert, G. L., Brookes, V., Thai, T., Wilson, A., Johnson, J.
BMJ Open, 18.11.2020 Tilføjet 19.11.2020 03:05Objectives As governments attempt to navigate a path out of COVID-19 restrictions, robust evidence is essential to inform requirements for public acceptance of technologically enhanced communicable disease surveillance systems. We examined the value of core surveillance system attributes to the Australian public, before and during the early stages of the current pandemic. Design A discrete choice experiment was conducted in Australia with a representative group of respondents, before and after the WHO declared COVID-19 a Public Health Emergency of International Concern. We identified and investigated the relative importance of seven attributes associated with technologically enhanced disease surveillance: respect for personal autonomy; privacy/confidentiality; data certainty/confidence; data security; infectious disease mortality prevention; infectious disease morbidity prevention; and attribution of (causal) responsibility. Specifically, we explored how the onset of the COVID-19 outbreak influenced participant responses. Setting and participants 2008 Australians (general public) completed the experiment: 793 before COVID-19 outbreak onset (mean age 45.9 years, 50.2% male) and 1215 after onset (mean age 47.2 years, 49% male). Results All seven attributes significantly influenced respondents’ preferences for communicable disease surveillance systems. After onset, participants demonstrated greater preference for a surveillance system that could prevent a higher number of illnesses and deaths, and were less concerned about their personal autonomy. However, they also increased their preference for a system with high data security. Conclusions Public acceptance of technology-based communicable disease surveillance is situation dependent. During an epidemic, there is likely to be greater tolerance of technologically enhanced disease surveillance systems that result in restrictions on personal activity if such systems can prevent high morbidity and mortality. However, this acceptance of lower personal autonomy comes with an increased requirement to ensure data security. These findings merit further research as the pandemic unfolds and strategies are put in place that enable individuals and societies to live with SARS-CoV-2 endemicity.
Læs mere Tjek på PubMedLiu, Y., Liu, C., Gao, M., Wang, Y., Bai, Y., Xu, R., Gong, R.
BMJ Open, 18.11.2020 Tilføjet 19.11.2020 03:05Objectives To evaluate a new-generation, non-invasive, wireless axillary thermometer with artificial intelligence, iThermonitor (WT705, Raiing Medical, Beijing, China), and to ascertain its feasibility for perioperative continuous body temperature monitoring in surgical patients. Setting Departments of Biliary Surgery and Operating Room and the post-anaesthesia care unit of a university teaching hospital in Chengdu, China. Participants A total of 526 adult surgical patients were consecutively enrolled. Design This was a prospective observational study. Axillary temperatures were continuously recorded with iThermonitor throughout the whole perioperative period. The temperatures of the contralateral armpit were measured with mercury thermometers at 8:00, 12:00, 16:00 and 20:00 every day and were used as references. Outcome measures The outcomes were the accuracy and precision of the temperatures measured with iThermonitor, the validity to detect fever and the feasibility of continuous wear. Pairs of temperatures were evaluated with Student’s t-test, Pearson’s correlation and repeated-measures Bland-Altman plot. Results A total of 3621 pairs of body temperatures were obtained. The temperatures measured with iThermonitor agreed with those measured with the mercury thermometers overall, with a mean difference of 0.03°C±0.35°C and a moderate correlation (r=0.755, p
Læs mere Tjek på PubMedRapoud, D., Quillet, C., Pham Minh, K., Vu Hai, V., Nguyen Thanh, B., Nham Thi Tuyet, T., Tran Thi, H., Moles, J.-P., Vallo, R., Michel, L., Feelemyer, J., Weiss, L., Lemoine, M., Vickerman, P., Fraser, H., Duong Thi, H., Khuat Thi Hai, O., Des Jarlais, D., Nagot, N., Laureillard, D., On behalf of the DRIVE-C Study Group
BMJ Open, 18.11.2020 Tilføjet 19.11.2020 03:05Introduction In Vietnam, people who inject drugs (PWID), who are the major population infected by hepatitis C virus (HCV), remain largely undiagnosed and unlinked to HCV prevention and care despite recommended universal hepatitis C treatment. The data on the outcomes of HCV treatment among PWID also remain limited in resource-limited settings. The DRug use & Infections in ViEtnam–hepatitis C (DRIVE-C) study examines the effectiveness of a model of hepatitis C screening and integrated care targeting PWID that largely uses community-based organisations (CBO) in Hai Phong, Vietnam. In a wider perspective, this model may have the potential to eliminate HCV among PWID in this city. Methods and analysis The model of care comprises large community-based mass screening, simplified treatment with direct-acting antivirals (DAAs) and major involvement of CBO for PWID reaching out, linkage to care, treatment adherence and prevention of reinfection. The effectiveness of DAA care strategy among PWID, the potential obstacles to widespread implementation and its impact at population level will be assessed. A cost-effectiveness analysis is planned to further inform policy-makers. The enrolment target is 1050 PWID, recruited from the DRIVE study in Hai Phong. After initiation of pan-genotypic treatment consisting of sofosbuvir and daclatasvir administrated for 12 weeks, with ribavirin added in cases of cirrhosis, participants are followed-up for 48 weeks. The primary outcome is the proportion of patients with sustained virological response at week 48, that will be compared with a theoretical expected rate of 70%. Ethics and dissemination The study was approved by Haiphong University of Medicine and Pharmacy's Ethics Review Board and the Vietnamese Ministry of Health. The sponsor and the investigators are committed to conducting this study in accordance with ethics principles contained in the World Medical Association's Declaration of Helsinki (Ethical Principles for Medical Research Involving Human Subjects). Informed consent is obtained before study enrolment. The data are anonymised and stored in a secure database. The study is ongoing. Results will be presented at international conferences and submitted to international peer-review journals. Trial registration number NCT03537196.
Læs mere Tjek på PubMedLowe, N. M., Zaman, M., Moran, V. H., Ohly, H., Sinclair, J., Fatima, S., Broadley, M. R., Joy, E. J. M., Mahboob, U., Lark, R. M., Zia, M. H., Ander, E. L., Sharp, P. A., Bailey, E. H., Young, S. D., Khan, M. J.
BMJ Open, 18.11.2020 Tilføjet 19.11.2020 03:05Introduction Micronutrient deficiencies, commonly referred to as ‘hidden hunger’, affect more than two billion people worldwide, with zinc and iron-deficiency frequently reported. The aim of this study is to examine the impact of consuming zinc biofortified flour (Zincol-2016) on biochemical and functional measures of status in adolescent girls and children living in a low-resource setting in Pakistan. Methods and analysis We are conducting a pragmatic, cluster-randomised, double-blind, controlled trial. A total of 482 households have been recruited from two catchment areas approximately 30–40 km distance from Peshawar. Household inclusion criteria are the presence of both an adolescent girl, aged 10–16 years, and a child aged 1–5 years. The study duration is 12 months, divided into two 6-month phases. During phase 1, all households will be provided with locally procured flour from standard varieties of wheat. During phase 2, clusters will be paired, and randomised to either the control or intervention arm of the study. The intervention arm will be provided with zinc biofortified wheat flour, with a target zinc concentration of 40 mg/kg. The control arm will be provided with locally procured wheat flour from standard varieties with an expected zinc concentration of 20 mg/kg. The primary outcome measure is plasma zinc concentration. Secondary outcomes include anthropometric measurements, biomarkers of iron and zinc status, and the presence and duration of respiratory tract infections and diarrhoea. Ethics and dissemination Ethical approval was granted from the University of Central Lancashire STEMH Ethics Committee (reference number: STEMH 1014) and Khyber Medical University Ethics Committee (DIR/KMU-EB/BZ/000683). The final study methods will be published in peer-reviewed journals, alongside the study outcomes. In addition, findings will be disseminated to the scientific community via conference presentations and abstracts and communicated to the study participants through the village elders at an appropriate community forum. Trial registration number ISRCTN17107812; Pre-results.
Læs mere Tjek på PubMed